Growth Metrics

Replimune (REPL) Change in Accured Expenses (2017 - 2025)

Replimune has reported Change in Accured Expenses over the past 9 years, most recently at -$1.9 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at -$1.9 million for Q4 2025, down 136.4% from a year ago — trailing twelve months through Dec 2025 was $4.6 million (down 18.69% YoY), and the annual figure for FY2025 was $11.7 million, up 27.17%.
  • Change in Accured Expenses reached -$1.9 million in Q4 2025 per REPL's latest filing, down from $2.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $9.2 million in Q1 2025 and bottomed at -$5.5 million in Q2 2025.
  • Median Change in Accured Expenses over the past 5 years was $1.2 million (2021), compared with a mean of $1.7 million.
  • The largest annual shift saw Change in Accured Expenses soared 4245.45% in 2021 before it crashed 333.99% in 2022.
  • Over 5 years, Change in Accured Expenses stood at $754000.0 in 2021, then surged by 277.45% to $2.8 million in 2022, then crashed by 130.01% to -$854000.0 in 2023, then soared by 715.46% to $5.3 million in 2024, then plummeted by 136.4% to -$1.9 million in 2025.
  • Business Quant data shows Change in Accured Expenses for REPL at -$1.9 million in Q4 2025, $2.8 million in Q3 2025, and -$5.5 million in Q2 2025.